DouglasJonSpriggsMD

Cardiology • Clearwater, FL

Adult Congenital Heart Disease, Interventional Cardiology

Physician

Join to view full profile

Dr. Spriggs is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Spriggs' full profile

Already have an account?

Office
455 Pinellas St
Suite 400
Clearwater, FL 33756
Phone+1 727-445-1911

Fax+1 727-445-1986

Education & Training

Corewell Health East Beaumont (Royal Oak)Post-Doctoral Fellowship, Interventional Cardiology, 1990 - 1991
University of MichiganFellowship, Cardiovascular Disease, 1988 - 1990
University of North Carolina HospitalsResidency, Internal Medicine, 1984 - 1987
The University of Toledo College of MedicineClass of 1984

Certifications & Licensure

FL State Medical License 1991 - 2026
NC State Medical License 1984 - 1999
MI State Medical License 1989 - 1993
American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014
Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Fellow (FACC) American College of Cardiology

Clinical Trials

PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - XT Intermediate and High Risk Start of enrollment: 2011 Mar 01
Completed
Not Applicable
ENDOvascular Interventions With AngioMAX: The ENDOMAX Trial Start of enrollment: 2013 Sep 24
Terminated
Phase 3
Medtronic Resolute Onyx 2.0 mm Clinical Study Start of enrollment: 2015 Apr 06
Completed
Not Applicable

Publications & Presentations

PubMed

572 citations
Effect of Platelet Inhibition with Cangrelor during PCI on Ischemic Events
Deepak L. Bhatt, Gregg W. Stone, Kenneth W. Mahaffey, C. Michael Gibson, P. Gabriel Steg
The New England Journal of Medicine. 2013-04-03
285 citations
Combined Accelerated Tissue-Plasminogen Activator and Platelet Glycoprotein IIb/IIIa Integrin Receptor Blockade With Integrilin in Acute Myocardial Infarction Results ...
E. Magnus Ohman, Neal S. Kleiman, Gerald Gacioch, Seth J. Worley, Frank I. Navetta
Circulation. 1997-02-18
907 citations
Bivalirudin and Provisional Glycoprotein IIb/IIIa Blockade Compared With Heparin and Planned Glycoprotein IIb/IIIa Blockade During Percutaneous Coronary Intervention: ...
A. Michael Lincoff, John A. Bittl, Robert A. Harrington, Frederick Feit, Neal S. Kleiman
JAMA. 2003-02-19

Press Mentions

Patients Reap Benefits from Heart Team's VisionMarch 29th, 2023
Pinellas Health NotesJuly 14th, 2008

Professional Memberships

American College of Cardiology - ACC
Fellow